Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 2021

View Archived Issues

Sanofi begins phase II study of SAR-443122 in cutaneous lupus erythematosus

Structural basis for the design of novel suramin derivatives as SARS-CoV-2 RdRp inhibitors

Enrollment opens in phase II study of RO-7049665 in autoimmune hepatitis

Dosing begins in phase I/II study of Covigenix VAX-001 for SARS-CoV-2

FDA clears XBiotech to begin phase I/II study of XB-2001 in pancreatic cancer

Peptron and Qilu sign licensing agreement for Peptron's PAb001-ADC

Zenshine PI3Kgamma inhibitor ZX-4081 functions by reprogramming the tumor microenvironment

FDA clears IND application for ALLO-605 for the treatment of multiple myeloma

Promising data reported from phase Ib ZUMA-19 study of lenzilumab in DLBCL

Genentech's GNE-7883 inhibits YAP/TAZ-TEAD interaction

Interim results show efficacy of gene therapy RP-L201 in pediatric leukocyte adhesion deficiency I

FDA clears IND to initiate LUMINOS-103 study of PVSRIPO in patients with advanced solid tumors

BeiGene patents new PROTACs for cancer

Roche discloses MGL inhibitors

Betta Pharmaceuticals identifies IDH2 mutant inhibitors

Suzhou Ark Biopharmaceutical identifies new compounds for HBV infection

Seoul National University discloses vaccine against SFTS virus

Tonix enters into worldwide licensing agreement with OyaGen to develop TNX-3500 for COVID-19

BO-2762: a potential candidate for colorectal cancer

Researchers give preclinical details on CARG-2020, an artificial oncolytic virus for ovarian cancer

TP-5809 shows potent inhibition of tumor growth in a model of Hodgkin's lymphoma

New phase III trial evaluates tafasitamab with lenalidomide and rituximab in FL and MZL

ZX-101A inhibits tumor growth by enhancing antitumor immunity

New technique casts light on stem cell differentiation

InterveXion reports phase II data on IXT-m200 in methamphetamine use disorder

European Commission approves Epidyolex for tuberous sclerosis complex

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...